Valsartan Tablet shortage
To Be Discontinued 4 presentations · 1 manufacturers · first FDA posting Nov 19, 2025 · last update Nov 19, 2025
Manufacturers: Mylan Pharmaceuticals Inc., a Viatris Company
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Valsartan, Tablet, 40 mg (NDC 0378-5807-93) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Nov 19, 2025 Updated Nov 19, 2025 Discontinued Nov 19, 2025 |
| Valsartan, Tablet, 80 mg (NDC 0378-5813-77) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Nov 19, 2025 Updated Nov 19, 2025 Discontinued Nov 19, 2025 |
| Valsartan, Tablet, 160 mg (NDC 0378-5814-77) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Nov 19, 2025 Updated Nov 19, 2025 Discontinued Nov 19, 2025 |
| Valsartan, Tablet, 320 mg (NDC 0378-5815-77) | Mylan Pharmaceuticals Inc., a Viatris Company | To Be Discontinued | — | A business decision was made to discontinue manufacture of the drug. | Posted Nov 19, 2025 Updated Nov 19, 2025 Discontinued Nov 19, 2025 |